Lataa...
Efficacy and safety of HAT1 compared with calcipotriol in the treatment of patients with mild to moderate chronic plaque psoriasis: results from an open‐label randomized comparative pilot clinical study
Psoriasis is commonly treated with topical corticosteroids, oral cytotoxic drugs and biologic agents, which can be associated with significant adverse effects (AEs), high cost and response attenuation. Additionally, patients often use alternative therapies ad hoc, which can be challenging to integra...
Tallennettuna:
| Julkaisussa: | Clin Exp Dermatol |
|---|---|
| Päätekijät: | , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
John Wiley and Sons Inc.
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7154690/ https://ncbi.nlm.nih.gov/pubmed/31419323 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/ced.14074 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|